Dermatitis  >>  Eucrisa (crisaborole)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eucrisa (crisaborole) / Pfizer
NCT04008784: Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period

Completed
N/A
16
US
Crisaborole 2% Topical Application Ointment [EUCRISA], Triamcinolone Acetonide 0.1% Ointment
Clinical Research Center of the Carolinas, Pfizer
Atopic Dermatitis
07/20
09/20
NCT03770858: Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Completed
N/A
23
US
Crisaborole, Scratch sensor
Northwestern University, Pfizer
Atopic Dermatitis
08/21
08/22
ChiCTR2100054340: Multi-center clinical efficacy and safety observation of sequential topical application of 0.1% mometasone furoate cream and 2% criborole ointment in the treatment of mild to moderate atopic dermatitis in children 2 years old and older

Not yet recruiting
N/A
156
 
Sequential topical application of mometasone furoate cream and crisaborole ointment ;Sequential topical application of mometasone furoate cream and emollients
Children's Hospital of Chongqing Medical University; Children's Hospital of Chongqing Medical University, China National Health Association
Atopic dermatitis
 
 

Download Options